Category: Business News
Dette nye tiltaket, som er en markant innstramming fra tidligere retningslinjer, tar sikte på å fremskynde tilgangen til nye og potensielt livsforbedrende legemidler for pasienter. Kravet fra Helseministeren kommuniseres i Tildelingsbrevet til Direktoratet for medisinske produkter (DMP). Men det er ikke aktuelt med forskriftsfesting av kravet, statssekretær Karl Kristian Bekeng (AP) i Helse- og omsorgsdepartementet (HOD) til […]
Source: Healthtalk.no
Category: Business News
Andreea Mocofan tar over ledelsen av MSD Norge den 1. mars – med forbehold om saksbehandlingstiden for arbeidstillatelse ettersom hun kommer fra et EU-land, skriver MSD Norge i en pressemelding. Mocofan, som skal lede 100 ansatte i Norge, overtar etter Muhammed «Mo» Ali, som fratrådte i fjor. Hun har ifølge selskapet bred erfaring fra PWC […]
Source: MedWatch
Category: Business News
Delivering on our commitment to fight infectious diseases for more than a century. For more than 100 years, MSD has contributed to the discovery and development of novel medicines and vaccines to fight infectious diseases. With the growing burden of antimicrobial resistance (AMR), we’ve focused on stopping the increasing threat of AMR. Read full article here.
Source: MSD
Category: Business News
How will Norway commercialise research and turn health into a green export success? The roadmap for the health industry was released today by Ingvild Kjerkol, Minister of Health and Care Services, and Jan Christian Vestre, Minister of Industry, Trade and Fisheries. The roadmap includes 12 focus areas and 41 actions, which the two ministries have worked […]
Source: Oslo Cancer Cluster
Category: Business News
NEW YORK & BOTHELL, Wash.–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) and Seagen Inc. (Nasdaq: SGEN) today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Seagen, a global biotechnology company that discovers, develops and commercializes transformative cancer medicines, for $229 in cash per Seagen share for a total enterprise […]
Source: Pfizer